A yearslong investigation of New York City’s $4 billion homeless shelter system has found widespread mismanagement, self-dealing and nepotism. The Department of Investigation's review of nonprofit org ...
GE HealthCare (Nasdaq: GEHC), the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF), teamed up to launch a new philanthropic endeavor, Powering Milwaukee Forward, aimed ...
Company worked with federal government to protect finished products in Florida and ramps up production at three manufacturing sites ...
All charges have been dismissed against a deaf Black man who was repeatedly punched and shocked with a Taser by Phoenix police officers. The August encounter was recorded on the ...
The United States says it is disappointed with a decision by the Swiss government not to adopt all measures in the latest round of European Union sanctions against Russia over ...
Warrior Run had a tough time containing Selinsgrove senior midfielder Gianna Gamble, who recorded a hat trick in a 4-1 win ...
When Kailey Buriak scored a goal on a breakaway with 2 minutes, 35 seconds left in the first quarter, it was just what Line ...
The closing of the offering is expected to occur on or about Oct. 21, 2024, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be ...
The former NBA champion Toronto Raptors have gone from “We The North” to “We The Rebuilding North.” It’s been five seasons since the Raptors rode their famous We The North ...
An Iranian newspaper implying that the public needed to have the patience of the Biblical figure Job in waiting for President Masoud Pezeshkian to lift restrictions on the internet now ...
Britain’s foreign secretary has called engagement with China “pragmatic and necessary” as he makes the first visit to the country by a Cabinet member from the Labor government that took ...
RM-HNSCC is one of eleven solid tumor cancers being studied in a multicenter national clinical trial, PREDAPT (clinical trials gov ID:NCT04510129), to evaluate OncoPrism’s ability to predict patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback